[HTML][HTML] Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions
The impact of radiotherapy on the heart has become an area of interest in recent years.
Many different cardiac dose-volume constraints have been associated with cardiac toxicity …
Many different cardiac dose-volume constraints have been associated with cardiac toxicity …
Cardiotoxicity of anticancer treatments: epidemiology, detection, and management
G Curigliano, D Cardinale, S Dent… - CA: a cancer journal …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Cancer and heart disease are the leading causes of
morbidity and mortality in the industrialized world. Modern treatment strategies have led to …
morbidity and mortality in the industrialized world. Modern treatment strategies have led to …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
AR Lyon, T Lopez-Fernandez, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
that, unless otherwise provided for by national regulations, offlabel use of medication should …
Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline
SH Armenian, C Lacchetti, A Barac, J Carver… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …
Risk of ischemic heart disease in women after radiotherapy for breast cancer
SC Darby, M Ewertz, P McGale… - … England Journal of …, 2013 - Mass Medical Soc
Background Radiotherapy for breast cancer often involves some incidental exposure of the
heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic …
heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic …
Cardiac toxicity after radiotherapy for stage III non–small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy
K Wang, MJ Eblan, AM Deal, M Lipner… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The significance of radiotherapy (RT)–associated cardiac injury for stage III non–
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …
Cardio-oncology: an update on cardiotoxicity of cancer-related treatment
CG Lenneman, DB Sawyer - Circulation research, 2016 - Am Heart Assoc
Through the success of basic and disease-specific research, cancer survivors are one of the
largest growing subsets of individuals accessing the healthcare system. Interestingly …
largest growing subsets of individuals accessing the healthcare system. Interestingly …
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline …
SH Armenian, MM Hudson, RL Mulder… - The Lancet …, 2015 - thelancet.com
Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …
are at an increased risk of developing congestive heart failure. In this population, congestive …
[HTML][HTML] Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G Curigliano, D Cardinale, T Suter, G Plataniotis… - Annals of oncology, 2012 - Elsevier
Cardiovascular (CV) toxicity is a potential short-or long-term complication of various
anticancer therapies. Some drugs, such as anthracyclines or other biological agents, have …
anticancer therapies. Some drugs, such as anthracyclines or other biological agents, have …
[HTML][HTML] Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations
BI Bodai, P Tuso - The Permanente Journal, 2015 - ncbi.nlm.nih.gov
Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good
news, but clinicians must also recognize that this brings new challenges to the medical …
news, but clinicians must also recognize that this brings new challenges to the medical …